471 related articles for article (PubMed ID: 32402251)
1. Leukemogenic Chromatin Alterations Promote AML Leukemia Stem Cells via a KDM4C-ALKBH5-AXL Signaling Axis.
Wang J; Li Y; Wang P; Han G; Zhang T; Chang J; Yin R; Shan Y; Wen J; Xie X; Feng M; Wang Q; Hu J; Cheng Y; Zhang T; Li Y; Gao Z; Guo C; Wang J; Liang J; Cui M; Gao K; Chai J; Liu W; Cheng H; Li L; Zhou F; Liu L; Luo Y; Li S; Zhang H
Cell Stem Cell; 2020 Jul; 27(1):81-97.e8. PubMed ID: 32402251
[TBL] [Abstract][Full Text] [Related]
2. RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia.
Shen C; Sheng Y; Zhu AC; Robinson S; Jiang X; Dong L; Chen H; Su R; Yin Z; Li W; Deng X; Chen Y; Hu YC; Weng H; Huang H; Prince E; Cogle CR; Sun M; Zhang B; Chen CW; Marcucci G; He C; Qian Z; Chen J
Cell Stem Cell; 2020 Jul; 27(1):64-80.e9. PubMed ID: 32402250
[TBL] [Abstract][Full Text] [Related]
3. Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m
Zhang L; Su X
Cell Oncol (Dordr); 2022 Jun; 45(3):355-365. PubMed ID: 35579750
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinase USP9X stabilizes RNA m
Wang P; Wang J; Yao S; Cui M; Cheng Y; Liu W; Gao Z; Hu J; Zhang J; Zhang H
J Biol Chem; 2023 Aug; 299(8):105055. PubMed ID: 37454738
[TBL] [Abstract][Full Text] [Related]
5. m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency.
Li G; Luo R; Zhang W; He S; Wang B; Liang H; Song Y; Ke W; Shi Y; Feng X; Zhao K; Wu X; Zhang Y; Wang K; Yang C
Clin Transl Med; 2022 Mar; 12(3):e765. PubMed ID: 35340126
[TBL] [Abstract][Full Text] [Related]
6. N
Zhu Z; Qian Q; Zhao X; Ma L; Chen P
Gene; 2020 Mar; 731():144348. PubMed ID: 31927006
[TBL] [Abstract][Full Text] [Related]
7. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential.
Qu J; Yan H; Hou Y; Cao W; Liu Y; Zhang E; He J; Cai Z
J Hematol Oncol; 2022 Jan; 15(1):8. PubMed ID: 35063010
[TBL] [Abstract][Full Text] [Related]
8. ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m
Gao Y; Zimmer JT; Vasic R; Liu C; Gbyli R; Zheng SJ; Patel A; Liu W; Qi Z; Li Y; Nelakanti R; Song Y; Biancon G; Xiao AZ; Slavoff S; Kibbey RG; Flavell RA; Simon MD; Tebaldi T; Li HB; Halene S
Cell Rep; 2023 Oct; 42(10):113163. PubMed ID: 37742191
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ALKBH5-mediated m
Guo Y; Song W; Yang Y
Environ Toxicol; 2022 Apr; 37(4):910-924. PubMed ID: 34995009
[TBL] [Abstract][Full Text] [Related]
10. m
Zhang S; Zhao BS; Zhou A; Lin K; Zheng S; Lu Z; Chen Y; Sulman EP; Xie K; Bögler O; Majumder S; He C; Huang S
Cancer Cell; 2017 Apr; 31(4):591-606.e6. PubMed ID: 28344040
[TBL] [Abstract][Full Text] [Related]
11. The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of
Li XC; Jin F; Wang BY; Yin XJ; Hong W; Tian FJ
Theranostics; 2019; 9(13):3853-3865. PubMed ID: 31281518
[TBL] [Abstract][Full Text] [Related]
12. M
Qiu X; Yang S; Wang S; Wu J; Zheng B; Wang K; Shen S; Jeong S; Li Z; Zhu Y; Wu T; Wu X; Wu R; Liu W; Wang HY; Chen L
Cancer Res; 2021 Sep; 81(18):4778-4793. PubMed ID: 34301762
[TBL] [Abstract][Full Text] [Related]
13. ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.
Han Z; Wang X; Xu Z; Cao Y; Gong R; Yu Y; Yu Y; Guo X; Liu S; Yu M; Ma W; Zhao Y; Xu J; Li X; Li S; Xu Y; Song R; Xu B; Yang F; Bamba D; Sukhareva N; Lei H; Gao M; Zhang W; Zagidullin N; Zhang Y; Yang B; Pan Z; Cai B
Theranostics; 2021; 11(6):3000-3016. PubMed ID: 33456585
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Pyrazolo[1,5-
Wang YZ; Li HY; Zhang Y; Jiang RX; Xu J; Gu J; Jiang Z; Jiang ZY; You QD; Guo XK
J Med Chem; 2023 Dec; 66(23):15944-15959. PubMed ID: 37983486
[TBL] [Abstract][Full Text] [Related]
15. K235 acetylation couples with PSPC1 to regulate the m
Zhang XL; Chen XH; Xu B; Chen M; Zhu S; Meng N; Wang JZ; Zhu H; Chen D; Liu JB; Yan GR
Nat Commun; 2023 Jun; 14(1):3815. PubMed ID: 37369679
[TBL] [Abstract][Full Text] [Related]
16. M
Liu X; Li P; Huang Y; Li H; Liu X; Du Y; Lin X; Chen D; Liu H; Zhou Y
Redox Biol; 2024 Feb; 69():102993. PubMed ID: 38104484
[TBL] [Abstract][Full Text] [Related]
17. RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification.
Li R; Wu X; Xue K; Feng D; Li J; Li J
Biomark Res; 2023 Mar; 11(1):30. PubMed ID: 36899424
[TBL] [Abstract][Full Text] [Related]
18. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
[TBL] [Abstract][Full Text] [Related]
19. The N
Li Z; Wang P; Li J; Xie Z; Cen S; Li M; Liu W; Ye G; Zheng G; Ma M; Wang S; Yu W; Wu Y; Shen H
Cell Death Dis; 2021 Jun; 12(6):578. PubMed ID: 34088896
[TBL] [Abstract][Full Text] [Related]
20. Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response.
Yu F; Wei J; Cui X; Yu C; Ni W; Bungert J; Wu L; He C; Qian Z
Nucleic Acids Res; 2021 Jun; 49(10):5779-5797. PubMed ID: 34048572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
